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Purpose: Nondegradable steel-and titanium-based implants are commonly used in
orthopedic surgery. Although they provide maximal stability, they are also associated
with interference on imaging modalities, may induce stress shielding, and additional
explantation procedures may be necessary. Alternatively, degradable polymer
implants are mechanically weaker and induce foreign body reactions. Degradable
magnesium-based stents are currently being investigated in clinical trials for use in
cardiovascular medicine. The magnesium alloy MgYREZr demonstrates good
biocompatibility and osteoconductive properties. The aim of this prospective,
randomized, clinical pilot trial was to determine if magnesium-based MgYREZr screws
are equivalent to standard titanium screws for fixation during chevron osteotomy in
patients with a mild hallux valgus.
Methods: Patients (n=26) were randomly assigned to undergo osteosynthesis using
either titanium or degradable magnesium-based implants of the same design. The 6
month follow-up period included clinical, laboratory, and radiographic assessments.
Results: No significant differences were found in terms of the American Orthopaedic
Foot and Ankle Society (AOFAS) score for hallux, visual analog scale for pain assessment,
or range of motion (ROM) of the first metatarsophalangeal joint (MTPJ). No foreign body
reactions, osteolysis, or systemic inflammatory reactions were detected. The groups were
not significantly different in terms of radiographic or laboratory results.
Conclusion: The radiographic and clinical results of this prospective controlled study
demonstrate that degradable magnesium-based screws are equivalent to titanium
screws for the treatment of mild hallux valgus deformities.
Keywords: Magnesium, Degradable, Hallux valgus, OsteosynthesisIntroduction
Currently, nondegradable implants are primarily made of steel or titanium. Although
these implants provide maximum stability, these nondegradable materials interfere
with imaging modalities, such as X-ray and magnetic resonance imaging, and often re-
quire an undesirable second operation to remove the implant [1,2]. Moreover, the
mechanical properties of nondegradable implants (steel or titanium) are quite different© 2013 Windhagen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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limiting the bone-healing process [3,4]. This constellation of effects defines “stress
shielding.” Therefore, it might be beneficial to use implants material with a Young’s
modulus close to that of cortical bone.
Currently, the most commonly used degradable implants are polymer-based. These
are mechanically weaker than metallic devices and are associated with foreign body re-
actions and osteolysis [5]. However, the first magnesium-based implants used at the be-
ginning of the 20th century exhibited high corrosion rates that consequently generated
subcutaneous gas cavities and reduced mechanical stability [6]. Recently developed
magnesium-based implants demonstrate improved anticorrosive and mechanical prop-
erties [1]. Degradable magnesium-based intravascular stents (WE43) yield good clinical
results and are biocompatible [7].
The present study investigated the use of the MAGNEZIXW compression screw
(Syntellix AG, Hannover, Germany). MAGNEZIXW is an aluminum-free magnesium
alloy that is classified as an MgYREZr alloy according to DIN EN 1753. This alloy con-
tains rare earth elements and is compositionally similar to WE43. It has already dem-
onstrated good biocompatibility and osteoconductive quality in vivo [8].
The chevron osteotomy is a distal “V-shaped” metatarsal osteotomy that was first de-
scribed by Austin and Leventen [9]. It is the operative option used to treat mild to
moderate hallux valgus deformities. The angle of the “V” is about 60° and results in the
impaction of the fragments without osteosynthesis. Recent studies have reported modi-
fication of the angulation and range of the limbs. The use of a greater angle and hori-
zontal osteotomy can maximize the contact surface, but osteosynthesis would be
necessary because fewer fragments would be impacted [10]. Loss of fixation and, conse-
quently, malunions and pseudarthrosis, have been reported following surgery without
fixation. Various studies have reported using K-wires, screws, staples, and plates [11];
however, screw fixation is mechanically superior to other modes of fixation [12].
The aim of this prospective, randomized clinical trial was to determine if the
MgYREZr alloy-based screw (MAGNEZIXW) demonstrates equivalent clinical and
radiographic outcomes to standard titanium screws in hallux valgus surgery.
Material and methods
Ethical approval
This prospective, randomized controlled study (according to EN ISO 14155–1:2009
and EN ISO 14155–2:2009) was approved by the ethics committee of medical school
hannover, monitored by an independent trial center, and conformed to the principles in
the Declaration of Helsinki. All participating patients provided voluntary written in-
formed consent.
Implants
The ends of the cannulated screws (shaft Ø, 2.0 mm; cannulation Ø, 1.3 mm) included
two threads (Ø 3.0 and 4.0 mm) with different pitches in order to achieve interfragment
compression [13]. The implants were made of a powdered metallurgically processed
magnesium alloy: this aluminum-free material consists of MgYREZr (a material similar
to WE43) that contains >90 wt% magnesium. With an average grain size of <5 μm, this
high-performance alloy demonstrates an offset elastic limit of Rp0.2>250 MPa, tensile
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same dimensions were used as the control (Figure 1).
Study design
Between March 2010 and July 2011, 26 patients (26 feet) with symptomatic hallux val-
gus were enrolled in this study (Table 1). The inclusion and exclusion criteria are
shown in Table 2. Patients were randomly assigned by the independent trial center
to either group before implantation without the knowledge of the medical investiga-
tors or surgeons. The study protocol included eight study visits (V1, preoperation;
V2, operation; V3, 1–3 days postoperation; V4, 4–8 days postoperation; V5, 2 weeks
postoperation; V6, 6 weeks postoperation; V7, 3 months postoperation; V8, 6 months
postoperation). Clinical examinations were performed at V1 and V3–8 and included de-
termination of the range of motion (ROM) of the first metatarsophalangeal joint
(MTPJ), American Orthopaedic Foot and Ankle Society (AOFAS) score for hallux, pain
level according to the visual analog scale (VAS), satisfaction rate (very satisfied, satisfied,
or unsatisfied with the results), and identification of any complications. Laboratory ana-
lyses (also performed at V1 and V3–8) included determination of magnesium levels in
the blood and urine, standard electrolytes (e.g., potassic, sodium, chloride, calcium, and
phosphate), renal parameters (e.g., urea, creatinine, and creatinine clearance) and liver
parameters (e.g., GOT, GPT, GammaGT, and alkaline phosphatase).
Surgical technique
A high tourniquet was placed at the thigh. Lateral release was performed over an inci-
sion that was placed between the first and second metatarsal bones. The musculus ad-
ductor hallucis tendon was released, and the lateral sesamoid was mobilized. The
medial approach was performed according to the technique described by Waizy et al.
[14]. The exostoses were removed, and the center of the metatarsal head was marked
with a 1.2 mm K-wire. An oscillating saw was used to perform a 90° chevron osteotomy.Figure 1 The two cannulated screws with the same design. a) The titanium screw (Fracture compressing
screw, Königsee Implantate GmbH, Am Sand 4, 07426 Allendorf, Germany), b) MAGNEZIXW Compression Screw
(Syntellix AG Schiffgraben 11, 30159 Hannover, Germany).
Table 1 Demographic informations of the study groups
Degradable implantgroup (DI) Titan implantgroup (TI)
mean SD mean SD
n 13 13
gender [w/m] 11/2 13/0
age [years] 57.2 7.2 49.9 16.5
weight [kg] 74.5 11.4 70.5 14.4
height [m] 1.68 7.0 1.68 9.1
BMI [kg/(m)2] 26.0 3.0 25.0 3.6
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according to the patient group. Temporary fixation with a threaded K-wire (1.2 mm)
was performed at the desired position of the screw. Intraoperative X-rays were acquired
to verify correct K-wire positioning and determine screw length. A two-step pilot drillbit
was used to make the countersunk hole in the head.
In the titanium group (TI), the compression screw was turned to generate compres-
sion, and the K-wire was removed after the screw was positioned. In the degradable
group (DI), additional predrilling was performed using a 2.0 mm diameter hand-
operated drill. The MgYREZr degradable compression screw was then inserted to ge-
nerate compression, and the K-wire was removed after the screw was positioned.
The overriding bone of the proximal metatarsal fragment was removed using an os-
cillating saw. The tourniquet was released, and the skin was sutured. Postoperative ban-
dages were applied by holding the big toe in the correct position.Radiography
All radiographs were conducted under standardized, weight-bearing conditions at
V1, V3, and V6–8. Posterior-anterior radiographs were used to measure the hallux
valgus angle (HVA), intermetatarsal angle (IMA), and the distal metatarsal articular
angle (DMAA). To determine the axis of the first metatarsal bone, a line was drawn
from the center of the head through the center of the base of the first metatarsal
bone. This is considered the most precise, least biased method for determiningTable 2 Inclusion and exclusion criteria of the study
Inclusion Exclusion
Symptomatic bunion with radiographic
correlates
Operations on the symptomatic foot in the past
Patients aged 40-79 BMI> 32
Female fertile patients: obligate practice of
two different secure contraceptive methods
Pregnancy or lactation
Normal function of the lower extremity Neurological pathologies
Bone mineral density abnormalities (e.g. radiographic detected
bone cysts in the first ray, manifested osteoporosis)
Allergies against study products (components of the screws)
Substitution of magnesia or manifested hepato-renal diseases
with possibel resulting bone mineral density abnormalities
Participation in other studies 30 days before the start of this
study and during the participation in this study
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orthopedic surgeons.
Postoperative treatment
The postoperative treatment regimens were the same for both groups. Postoperative
dressings were removed between the first and third postoperative days (V1–3). The big
toe was held and stabilized in the correct position using hallux valgus wool and crepe
bandages for 6 weeks, and the bandages were changed twice a week. Physiotherapy with
only passive MTPJ mobilization was initiated after the removal of the first dressings.
Sutures were removed 2 weeks after surgery (V5). For 6 weeks, full weight-bearing
mobilization was allowed when wearing an orthotic shoe with a stiff sole. High-impact
sports were allowed after 12 weeks.
Statistics
Significant differences in VAS and AOFAS scores for hallux were determined using
t tests (IBM-SPSS version 20; Armonk, NY, USA). In this study, p<0.05 was consid-
ered statistically significant.
Results
This clinical study was performed between March 2010 and February 2012 without
interruption. Follow-up examinations were performed on 12 patients per group. One
patient in each group dropped out of the study after surgery for personal reasons.
Complications did not occur in any patients during the follow-up period.
Both groups demonstrated good to excellent results, including improvements in
AOFAS score for hallux, and no significant differences were identified in any of the
outcome measures (Figure 2). A total of 23 of 24 patients were very satisfied and indi-
cated that they would undergo the same operation again. One patient in the DI group
developed a superficial wound-healing problem and was unsatisfied. None of the pa-
tients developed a palpable gas cavity. VAS decreased in both groups (Figure 3). No sig-
nificant differences were observed between visits.
MTPJ stiffness was not observed. All patients demonstrated minimum passive ROM of
60° and minimum active ROM of 50° at the MTPJ. The mean (standard deviation) oper-
ation time was 40.0 (9.1) minutes for the DI group and 34.0 (3.3) minutes for the TI group.Figure 2 Preoperativ (V1) and postoperative AOFAS score for hallux. There is no significant difference
between the improvement of the two groups (bars =mean value with standard deviation).
Figure 3 Preoperativ (V1) and postoperative VAS scores. There is no significant difference between the
improvement of the two groups (bars = mean value with standard deviation).
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There were no significant differences between groups on the follow-up chemical
or urine analyses.
HVA, IMA, and DMAA improved in both groups (Table 3), and the pre- and postop-
erative radiographs are shown in Figure 4. The postoperative X-rays demonstrated no
signs of avascular necrosis, no bone erosion due to the development of gas cavities, and
no advanced arthritis in the MTPJ. The healing rate was 100%. None of the screws had
to be removed during the study. Although 1 patient in the TI group developed a symp-
tomatic screw head, she refused to have the screw removed during the 6 month follow-
up period for personal reasons. The screw was removed 8 months after implantation.
All adverse effects and complications were documented. General adverse events
noted during this study included postoperative sickness (n=3, 2 DI and 1 TI patient)
and pneumonia at 5 months after the operation (n=1 TI patient).
Three superficial wound complications developed and demonstrated delayed wound
healing (2 DI patients and 1 TI patient). Infections were ruled out by laboratory ana-
lysis and clinical inspection. All 3 wounds healed without revision. No allergic reactions
or further systemic reactions were observed in either group. Complex regional pain
syndrome (CRPS) and severe adverse effects were not observed.Discussion
The chevron osteotomy has shown good to excellent clinical results in mild to mode-
rate hallux valgus, with high patient satisfaction rates. Those results were mostly basedTable 3 The IMA, HVA and DMAA preoperative and postoperative after 6 months
Degradable implantgroup (DI) Titan implantgroup (TI)
mean SD mean SD
IMA Preop. 12.88 1.82 12.58 1.44
6 months 7.67 2.89 6.04 2.49
HVA Preop. 24.03 7.59 23.53 0.52
6 months 16.19 8.93 11.76 6.41
DMAA Preop. 11.01 5.05 12.91 6.96
6 month 7.28 4.07 5.43 2.64
Figure 4 Preoperative radiographs (posterior-anterior) of a mild hallux valgus deformity. The
correction is achieved by a chevron osteotomy. The postoperative radiographs show a bony healing in
both groups.
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both groups showed good to excellent clinical and radiographic results with a high
satisfaction rate. The equivalent clinical outcomes were considered a result of the
operative procedure, and we did not detect any influence of the implant on the
clinical features.
The degradation of an implant can necessitate an undesirable second operative ther-
apy for implant removal. Besides the additional cost, further problems may develop due
to elevated infection risk associated with implant removal [17]. Also, up to 20% of pa-
tients develop new symptoms after a second surgery to remove the implant [18].
Coughlin reported that additional operative procedures for implant removal (screws,
plates, pins) were necessary in 15% of patients with hallux valgus [19]. In the present
study, no implant removals were necessary during the first 6 months after surgery. This
may be attributable to the design of the screw, which lacked a prominent screw head.
The implant removal rate due to soft tissue irritation was reported to be low with the
head design of the Herbert screw [20]. However, because this study had a relatively
short follow-up period and reduced irritation due to the screw head design, it was diffi-
cult to show the potential benefit of degradable screws given the reduction in redun-
dant surgery.
Degradable implants are currently in clinical use for fixation in chevron osteotomy.
The clinical outcome is excellent for both degradable and nondegradable implants.
Caminear et al. retrospectively studied a series of 18 chevron osteotomies fixed with co-
polymer pins and observed high AOFAS scores (87.4±14.9) and only one giant cell
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used clinical scoring system. Small et al. conducted a retrospective study of 71 chevron
osteotomies fixed with degradable polymer pins and reported a 100% bone healing rate,
but osteolysis appeared in 5.6% of cases [22]. The only previous comparative study
(chevron osteotomy: polymer pins vs. permanent K-wires) was reported by Gill et al.
[23]. No differences were found regarding the prevalence of clinical symptomatic com-
plications, but osteolysis was observed in 10.2% of patients in the polymer-based group.
In our study, 3 (2 DI and 1 TI) patients experienced delayed wound healing. Fur-
ther studies with a greater number of patients are necessary to identify a possible
clinical difference.
Stable fixation with accelerated bone healing reduces immobilization time and the
risk of developing joint stiffness. In contrast to polymer-based implants, magnesium
alloys showed promising biomechanical results in vitro [24,25] and in vivo [26]. The
in vivo results also attributed an osteoconductive quality to the magnesium alloy MgYREZr
[8]. This would facilitate early bone healing, and consequently, faster mobilization
with early recovery, which would potentially benefit the patients. Further studies
should test this osteoconductive hypothesis by measuring bone healing velocity.
The use of degradable magnesium implants is controversial. The degradation process
produces hydrogen gas, and gas cavities have been described. The source of the gas
cavities remains an issue of debate [27]. In clinical use, gas formation would be an obs-
tacle to bone and wound healing. Waizy et al. performed a rabbit study with a 1 year
follow-up to test the alloy MgYREZr and found no bone erosion due to gas cavities [8].
Corrosion occurs in both degradable and permanent implants. Implant wear may
cause the accumulation of particles around implants that stimulate inflammation,
osteoclast activation, and osteoblast inhabitation. This pathway induces osteolysis and
may also trigger hypersensitivity and allergic reactions [28]. Witte et al. previously de-
monstrated that the magnesium alloy WE43 was nonallergenic in an epicutaneous
patch test [29]. MgYREZr is similar to WE43; therefore, we hypothesized that it may
also have a nonallergic composition. We did not observe any cases of allergic reaction
during follow-up.
The degradation of a magnesium alloy can potentially induce a systemic inflamma-
tory reaction or pathologic changes in visceral organs. However, to date, no in vivo
studies have reported either of those adverse events [30]. Waizy et al. postulated that
MgYREZr would have good biocompatibility due to the absence of acute, subacute, and
chronic systematic inflammatory reactions and the absence of specific pathologic
changes in the visceral organs in an in vivo study [8]. The present clinical study con-
firmed the good clinical outcome hypothesized for this degradable magnesium alloy.
The primary limitation of this study was the relatively short follow-up time, and fu-
ture studies should be focused on long-term consequences. We set the endpoint of the
study at 6 months follow-up because this was the typical endpoint for operative hallux
valgus therapy at our institution. At 6 months, complete bone healing should be
attained, and further radiographic controls should not be necessary. We were not able
to verify complete screw degradation; however, based on in vivo results from Waizy
et al., it is reasonable to assume that the magnesium alloy was completely or nearly
completely degraded [8]. Another limitation of our study was the relatively low statis-
tical power of the radiographic measurements. However, we could show an equivalent
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complications. The strength of this study is that it is the first prospective, randomized,
single surgeon study to investigate a degradable, magnesium-based implant.Conclusion
This pilot study demonstrated that the degradable magnesium-based screw was radio-
graphically and clinically equivalent to the conventional titanium screw. We did not ob-
serve any instances of foreign body reaction, osteolysis, or systemic inflammatory
reaction. Larger prospective randomized trials with a longer follow-up are needed to
confirm the findings of this study.
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